Managing mitral regurgitation: Focus on the MitraClip device

J. Trent Magruder, Todd C. Crawford, Joshua C. Grimm, Joseph L. Fredi, Ashish S. Shah

Research output: Contribution to journalArticlepeer-review


Based on the principle of surgical edge-to-edge mitral valve repair (MVR), the MitraClip percutaneous MVR technique has emerged as a minimally invasive option for MVR. This catheter-based system has been widely demonstrated to be safe, although inferior to surgical MVR. Studies examining patients with ≥3+ mitral regurgitation (MR) show that, for all patients treated, freedom from death, surgery, or MR ≥3+ is in the 75%-80% range 1 year following MitraClip implantation. Despite its inferiority to surgical therapy, in high-risk surgical patients, data suggest that the MitraClip system can be employed safely and that it can result in symptomatic improvement in the majority of patients, while not precluding future surgical options. MitraClip therapy also appears to reduce heart failure readmissions in the high-risk cohort, which may lead to an economic benefit. Ongoing study is needed to clarify the impact of percutaneous mitral valve clipping on long-term survival in high-risk populations, as well as its role in other patient populations, such as those with functional MR.

Original languageEnglish (US)
Pages (from-to)53-60
Number of pages8
JournalMedical Devices: Evidence and Research
StatePublished - Apr 12 2016
Externally publishedYes


  • Cardiac surgery
  • Mitral clips
  • Mitral regurgitation
  • Percutaneous
  • Transcatheter

ASJC Scopus subject areas

  • Biomedical Engineering
  • Medicine (miscellaneous)


Dive into the research topics of 'Managing mitral regurgitation: Focus on the MitraClip device'. Together they form a unique fingerprint.

Cite this